This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Carmen Cascales: Innovator in Farnesyl-Protein Transferase Inhibition
Introduction
Carmen Cascales is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit farnesyl-protein transferase (FPTase). Her work is crucial in the fight against cancer, as it targets the oncogene protein Ras, which is often implicated in tumor growth.
Latest Patents
Carmen holds a patent for her invention titled "Inhibitors of Farnesyl-Protein Transferase." This patent describes non-peptide compounds that effectively inhibit FPTase and the farnesylation process of the oncogene protein Ras. The invention also outlines a method for preparing these compounds through the cultivation of a culture of Phoma sp. Additionally, it includes chemotherapeutic compositions that utilize these compounds and methods for their application in cancer treatment.
Career Highlights
Carmen Cascales is currently associated with Merck & Co., Inc., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the pharmaceutical industry, contributing to advancements in cancer therapies.
Collaborations
Carmen has collaborated with notable colleagues, including Russell B Lingham and Fernando Pelaez. These partnerships have enhanced her research and expanded the impact of her inventions in the scientific community.
Conclusion
Carmen Cascales is a trailblazer in the field of biochemistry, with her patent on farnesyl-protein transferase inhibitors representing a significant advancement in cancer treatment. Her contributions continue to inspire future innovations in the pharmaceutical industry.